TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014